Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)

7.89
Delayed Data
As of Feb 10
 -0.08 / -1.00%
Today’s Change
7.35
Today|||52-Week Range
17.00
-31.92%
Year-to-Date
No recent news for Ironwood Pharmaceuticals Inc.

Today’s Trading

Previous close7.97
Today’s open8.05
Day’s range7.83 - 8.25
Volume1,537,658
Average volume (3 months)1,222,662
Market cap$1.1B
Dividend yield--
Data as of 02/10/2016

Growth & Valuation

Earnings growth (last year)+40.85%
Earnings growth (this year)+24.52%
Earnings growth (next 5 years)+27.00%
Revenue growth (last year)+234.06%
P/E ratioNM
Price/Sales27.42
Price/Book12.67

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...-0.42-1.58%
INSYINSYS Therapeutics I...+0.99+6.30%
PBYIPuma Biotechnology I...+1.05+2.96%
TXMDTherapeuticsMD Inc-0.03-0.49%
Data as of 02/10/2016

Financials

Next reporting dateFebruary 18, 2016
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$76.4M
Annual profit (last year)-$189.6M
Net profit margin-248.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Peter M. Hecht
Chief Financial Officer &
SVP-Corporate Strategy
Thomas Graney
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers